We evaluated the influence of clinical, biochemical, and genetic factors on response in 142
patients diagnosed with rheumatoid arthritis, of whom 87 patients were treated with …

In the present study, we aimed to investigate the influence of clinical parameters and single-
nucleotide polymorphisms of interleukin-6 receptor (rs12083537, rs2228145, rs4329505 …

The aim of this study was to investigate the influence of clinical and genetic factors on
response to tocilizumab (TCZ) response, remission, low disease activity (LDA) and DAS28 …

Chemotherapy based on platinum compounds is the standard treatment for NSCLC patients
with EGFR wild type, and is also used as second line in mutated EGFR patients …

Platinum-based chemotherapy is the standard treatment for NSCLC patients with EGFR wild-
type, and as alternative to failure to EGFR inhibitors. However, this treatment is aggressive …

Abstract Rationale: Vitamin K antagonists (VKA), such as warfarin and acenocoumarol, are
widely used for the prevention and treatment of thromboembolic diseases and they are …

Background Surgery is the standard treatment for early-stage NSCLC, and platinum-based
chemotherapy remains as the treatment of choice for advanced-stage NSCLC patients with …

Breast cancer (BC) is the most common cause of cancer-related death in women worldwide.
Several ABCB1 and VEGFA gene polymorphisms, such as ABCB1-G1199 T/A (rs2229109) …

First-line therapy with interferon beta (IFN-β), involved in gene expression modulation in
immune response, is widely used for multiple sclerosis. However, 30–50% of patients do not …

Background This study aims to establish and validate a predictive nomogram for the short‐
term clinical outcomes of myasthenia gravis (MG) patients treated with low‐dose rituximab …